Author

Stephanie I Walter

Seattle Children's Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Aya MiyakiiD· 1 shared Elizabeth R. LawloriD· 1 shared Emma D. WrenniD· 1 shared Jonah R. Valenti· 1 shared Marina ChaniD· 1 shared Neerja KatiyariD· 1 shared Nicolas M. GarciaiD· 1 shared Shireen S. GanapathiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aya MiyakiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Transcriptional Rewiring of BET Inhibitor Treated Ewing Sarcoma Cells Augments their Dependency on Focal Adhesion Kinase

Shireen S. Ganapathi, Emma D. Wrenn, Nicolas M. Garcia, Neerja Katiyar, Stephanie I Walter, Aya Miyaki, Jonah R. Valenti, Yuqi Kang, Marina Chan, Taranjit S. Gujral, Elizabeth R. Lawlor

This study shows that BET inhibitor treatment rewires Ewing sarcoma transcription, increasing dependency on FAK, and that combining BET and FAK inhibitors synergistically reduces tumor growth.

bioRxiv · Sep 2, 2025 · PreprintCancer Biology